Li et al. [25] adopted a support vector machine model to predict the genetic characteristics of ATRX. Given that their method is only effective for low-grade gliomas, the tumor grade should be known in advance, complicating the use of their method in the preoperative period. This evidence concerns the gene ATRX and central nervous system cancer.